Joyce N. Barlin

2.0k total citations
38 papers, 1.1k citations indexed

About

Joyce N. Barlin is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Joyce N. Barlin has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Reproductive Medicine, 20 papers in Obstetrics and Gynecology and 12 papers in Surgery. Recurrent topics in Joyce N. Barlin's work include Ovarian cancer diagnosis and treatment (26 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Intraperitoneal and Appendiceal Malignancies (10 papers). Joyce N. Barlin is often cited by papers focused on Ovarian cancer diagnosis and treatment (26 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Intraperitoneal and Appendiceal Malignancies (10 papers). Joyce N. Barlin collaborates with scholars based in United States, Canada and Germany. Joyce N. Barlin's co-authors include Richard R. Barakat, Nadeem R. Abu‐Rustum, Fady Khoury‐Collado, Yukio Sonoda, Christine H. Kim, S. Dennis, Robert E. Bristow, Mario M. Leitão, Martee L. Hensley and Isha Puri and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Gynecologic Oncology.

In The Last Decade

Joyce N. Barlin

36 papers receiving 1.1k citations

Peers

Joyce N. Barlin

EPIDE

SURGE

PRM

Harushige Yokota Japan

Mariam AlHilli United States

Jan Hauspy Belgium

Fuat Demirkıran Türkiye

Elisa Piovano Italy

Bradford P. Whitcomb United States

Shashikant B. Lele United States

David P. Schammel United States

Tullio Golia D’Augè Italy

Summer Dewdney United States

Harushige Yokota Japan

Joyce N. Barlin

484 ×0.6

697 ×1.0

204 ×0.8

EPIDE

382 ×1.7

SURGE

124 ×0.8

PRM

Citations per year, relative to Joyce N. Barlin Joyce N. Barlin (= 1×) peers Harushige Yokota

Countries citing papers authored by Joyce N. Barlin

Since Specialization

Citations

This map shows the geographic impact of Joyce N. Barlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce N. Barlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce N. Barlin more than expected).

Fields of papers citing papers by Joyce N. Barlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce N. Barlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce N. Barlin. The network helps show where Joyce N. Barlin may publish in the future.

Co-authorship network of co-authors of Joyce N. Barlin

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce N. Barlin. A scholar is included among the top collaborators of Joyce N. Barlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce N. Barlin. Joyce N. Barlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barlin, Joyce N., Ashar Ata, Béatrice Cormier, et al.. (2023). Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma. Gynecologic Oncology. 180. 63–69. 3 indexed citations

Secord, Angeles Alvarez, Lisa Barroilhet, Myong Cheol Lim, et al.. (2022). FLORA-5/GOG3035: Frontline chemo-immunotherapy (paclitaxel-carboplatin-oregovomab [PCO] versus chemotherapy (paclitaxel-carboplatin-placebo [PCP]) in patients with advanced epithelial ovarian cancer (EOC)—Phase III, double-blind, placebo-controlled, global, multinational study.. Journal of Clinical Oncology. 40(16_suppl). TPS5619–TPS5619. 3 indexed citations

Okamoto, Aikou, Gini F. Fleming, Michael A. Bookman, et al.. (2020). 818P Veliparib with carboplatin and paclitaxel in frontline high-grade serous ovarian cancer (HGSOC): Efficacy and safety of paclitaxel weekly and every 3 weeks in the VELIA study. Annals of Oncology. 31. S618–S618. 2 indexed citations

Suidan, R.S., Caryn M. St. Clair, Joyce N. Barlin, et al.. (2014). A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer. Gynecologic Oncology. 134(3). 468–472. 7 indexed citations

Barlin, Joyce N., Qin Zhou, Caryn M. St. Clair, et al.. (2013). Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees. Gynecologic Oncology. 130(3). 452–456. 79 indexed citations

Barlin, Joyce N., K. Long, Edward J. Tanner, et al.. (2013). Optimal (≤1cm) but visible residual disease: Is extensive debulking warranted?. Gynecologic Oncology. 130(2). 284–288. 19 indexed citations

Kim, Christine H., Robert A. Soslow, Kay J. Park, et al.. (2013). Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes During Endometrial Cancer Staging. International Journal of Gynecological Cancer. 23(5). 964–970. 206 indexed citations

Barlin, Joyce N., Robert A. Soslow, Qin Zhou, et al.. (2013). Redefining Stage I Endometrial Cancer. International Journal of Gynecological Cancer. 23(9). 1620–1628. 34 indexed citations

Barlin, Joyce N., et al.. (2013). Recurrent cervical cancer isolated to the sigmoid colon: A case report. PubMed. 6. 28–30. 4 indexed citations

10.

Barber, Emma L., Fady Khoury‐Collado, Joyce N. Barlin, et al.. (2013). Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Gynecologic Oncology. 130(1). e73–e73. 25 indexed citations

11.

Barlin, Joyce N., et al.. (2012). Nanometastases of endometrial carcinoma to sentinel lymph nodes: The contribution of pathologic ultrastaging. Gynecologic Oncology. 125. S154–S154. 1 indexed citations

12.

Barlin, Joyce N., Fady Khoury‐Collado, Christine H. Kim, et al.. (2012). The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: Beyond removal of blue nodes. Gynecologic Oncology. 125(3). 531–535. 299 indexed citations

13.

Barlin, Joyce N., Fanny Dao, Sarah E. Ferguson, et al.. (2012). Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic Oncology. 125(3). 621–624. 36 indexed citations

14.

Barlin, Joyce N., Petar Jelinic, Narciso Olvera, et al.. (2012). Validated gene targets associated with curatively treated advanced serous ovarian carcinoma. Gynecologic Oncology. 128(3). 512–517. 42 indexed citations

15.

Barlin, Joyce N., Weiya Z. Wysham, Fady Khoury‐Collado, et al.. (2012). Location of Disease in Patients Who Die From Endometrial Cancer. International Journal of Gynecological Cancer. 22(9). 1527–1531. 13 indexed citations

16.

Barlin, Joyce N., Fanny Dao, Sarah E. Ferguson, et al.. (2012). Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin is comparable to results from GOG 172. Gynecologic Oncology. 125. S36–S37. 1 indexed citations

17.

Barlin, Joyce N., Changhong Yu, Emily K. Hill, et al.. (2011). Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. Gynecologic Oncology. 125(1). 25–30. 53 indexed citations

18.

Barlin, Joyce N., et al.. (2010). Computed tomographic peritoneography prior to intraperitoneal chemotherapy in advanced müllerian cancer: a pilot study. Clinical Imaging. 34(3). 191–195. 2 indexed citations

19.

Barlin, Joyce N., Isha Puri, & Robert E. Bristow. (2010). Cytoreductive surgery for advanced or recurrent endometrial cancer: A meta-analysis. Gynecologic Oncology. 118(1). 14–18. 120 indexed citations

20.

Dennis, S., Joyce N. Barlin, Pedro T. Ramírez, et al.. (2010). Follow-Up Study of the Correlation Between Postoperative Computed Tomographic Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, or Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease of 1 cm or Smaller. International Journal of Gynecological Cancer. 20(3). 353–357. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact